Literature DB >> 22398232

Lichen planus pigmentosus-inversus: case report and review of an unusual entity.

Erich Gaertner1, William Elstein.   

Abstract

Lichen planus pigmentosus-inversus is a rare variant of lichen planus, with less than 20 cases reported in the medical literature. It presents as asymptomatic to mildly pruritic, hyperpigmented macules and/or patches involving intertriginous and flexural areas and skin folds in light-skinned individuals. The unique pattern of skin involvement, clinical features, and histology are distinctive. The combination of hyperpigmented lesion(s) isolated to non-sun exposed, intertriginous, and flexural areas with lichenoid histology is unique and separates it from other similar entities, such as lichen planus actinus and erythema dyschromicum perstans/ashy dermatosis. The case well highlights this unusual condition and represents the first case reported in the United States.

Entities:  

Mesh:

Year:  2012        PMID: 22398232

Source DB:  PubMed          Journal:  Dermatol Online J        ISSN: 1087-2108


  4 in total

1.  Combination Therapy of Acitretin Capsule and Chinese Herbs for Patients with Lichen Planus Pigmentosus-Inversus.

Authors:  Yu Chen; Liang Xue; Dong-Jie Guo; Jing-Yi Mao; Min-Feng Wu; Rong Xu; Xin Li; Bin Li; Fu-Lun Li
Journal:  Chin J Integr Med       Date:  2019-08-24       Impact factor: 1.978

2.  Lichen planus pigmentosus inversus.

Authors:  Hugo Rocha Barros; José Roberto Paes de Almeida; Sandra Lopes Mattos e Dinato; Angelo Sementilli; Ney Romiti
Journal:  An Bras Dermatol       Date:  2013 Nov-Dec       Impact factor: 1.896

Review 3.  Cutaneous and mucosal lichen planus: a comprehensive review of clinical subtypes, risk factors, diagnosis, and prognosis.

Authors:  Farzam Gorouhi; Parastoo Davari; Nasim Fazel
Journal:  ScientificWorldJournal       Date:  2014-01-30

Review 4.  Lichen Planus Pigmentosus: The Controversial Consensus.

Authors:  Aparajita Ghosh; Arijit Coondoo
Journal:  Indian J Dermatol       Date:  2016 Sep-Oct       Impact factor: 1.494

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.